HLA-A and cancer: Despite differences between human and mouse transcriptomes33,34, the syngeneic HLA-A*02:01-transgenic cancer model provides the opportunity to test for potential cross-reactivities to a multitude of HHD-presented peptides that are found on healthy murine tissues.